Antibiotic resistance is a growing global health crisis, posing a significant threat to modern medicine. The emergence of drug-resistant strains of bacteria has made it increasingly challenging to treat common infections. Amidst this challenge, Mu138, a innovative antibiotic candidate, is emerging as a potential breakthrough. Preclinical studies h